19 trends tracked about this subject — the full history, oldest to newest below.
Actor Tyler Mane's male breast cancer diagnosis has sparked conversations about men's health awareness
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.
A leading oncologist is challenging traditional wellness norms by promoting six specific habits to increase longevity and reduce chronic illness risk.
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A study from Imperial College Healthcare NHS Trust indicates focal therapy for prostate cancer matches surgery and radiotherapy in efficacy.
Medical discussions are intensifying over whether GLP-1 medications like Ozempic can prevent cancer or influence oncology recovery.
A new treatment for metastatic pancreatic cancer and KRAS-mutated cancers is generating optimism among experts and patients.
New data suggests a second PSMA PET scan can alter treatment plans for nearly half of patients with prostate cancer.
Anthropic has launched a dedicated research workbench for oncology and drug discovery, prompting broad analysis of AI integration in scientific laboratories.
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
New research identifies distinct subgroups of acute myeloid leukemia through epigenetic mapping.
Recent study findings indicate lung transplants may improve survival outcomes for patients diagnosed with stage 4 lung cancer.
A large-scale study has identified specific microbiomes residing within cancer tumors, signaling a shift in how oncology researchers view microbial interactions.
A new report indicates a projected surge in global cancer cases over the coming decades, highlighting significant disparities in medical progress.
New reports and expert analysis address the prevalence of cancer and the persistence of care inequities across the United States.
Researchers have discovered a drug that blocks 90% of pancreatic cancer cell migration in laboratory tests.
An experimental drug for pancreatic cancer is generating hope among medical professionals and patients.
Medical professionals express concern as cancer patients increasingly opt for ivermectin over chemotherapy.